The aim of this feasibility study was to assess the lipid-lowering effects and safety of a Ayurveda formulation containing Terminalia Arjuna, Withania Sominifera, Garcinia Cambogia and piperine (as bioenhancer)

The COVID-19 related lockdowns severely affected the healthcare in India, specially in second wave of COVID-19. This research presents the applicability of Ayurveda formulation to analyze the impact on lipid profile during the lockdown.

Patients with hyperlipidemia who referred to Gyansanjeevani were recruited. All participants were enrolled in the study after a complete physical examination and medical history remotely over the virtual secure platform.

Inclusion Criteria:

• Age between 18 and 65 years
• BMI between 18.5 and 40 kg/m2
• Total Cholesterol >180 mg/dl
• No clinically significant medical history
• Willing to participate to the study by complying with the protocol
• Able to provide written informed consent

Exclusion Criteria:

• Metabolic disorder such as diabetes, uncontrolled thyroidal trouble or other metabolic disorder,
• Severe chronic disease
• History of ischemic cardiovascular event,
• Uncontrolled hypertension
• Under treatment or dietary supplement which could affect study parameter